Gallivac IB88
Gallivac IB88
Authorised
- Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Product identification
Medicine name:
Gallivac IB88
Active substance:
- Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Target species:
-
Chicken
Route of administration:
-
Topical
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type 793/B, strain CR88121, Live0.60/50% Embryo Infective Dose1.00Dose
Pharmaceutical form:
-
Oral spray, suspension
Withdrawal period by route of administration:
-
Topical
- Chicken
-
Meat and offal0day
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 230a/97
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 27/04/2022
How useful was this page?:
